171 related articles for article (PubMed ID: 22785086)
1. Changing illness perceptions and adherence to dual antiplatelet therapy in patients with stable coronary disease.
Fennessy MM; Devon HA; Ryan C; Lopez JJ; Zerwic JJ
J Cardiovasc Nurs; 2013; 28(6):573-83. PubMed ID: 22785086
[TBL] [Abstract][Full Text] [Related]
2. Dual antiplatelet therapy in patients with stable coronary artery disease in modern practice: prevalence, correlates, and impact on prognosis (from the Suivi d'une cohorte de patients COROnariens stables en region NORd-Pas-de-Calais study).
Lemesle G; Lamblin N; Meurice T; Tricot O; Lallemant R; Nugue O; Delomez M; Equine O; Tondeux S; Bauters C
Am Heart J; 2014 Oct; 168(4):479-86. PubMed ID: 25262257
[TBL] [Abstract][Full Text] [Related]
3. Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial.
Dangas GD; Claessen BE; Mehran R; Xu K; Stone GW
EuroIntervention; 2013 Jan; 8(9):1033-9. PubMed ID: 23339809
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
Kocas C; Abaci O; Oktay V; Coskun U; Bostan C; Yildiz A; Arat Ozkan A; Gurmen T; Ersanli M
J Clin Pharm Ther; 2013 Dec; 38(6):476-9. PubMed ID: 23992279
[TBL] [Abstract][Full Text] [Related]
5. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.
Resor CD; Nathan A; Kereiakes DJ; Yeh RW; Massaro JM; Cutlip DE; Gabriel Steg P; Hsieh WH; Mauri L;
Circulation; 2016 Oct; 134(14):989-998. PubMed ID: 27576774
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
7. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ;
Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503
[TBL] [Abstract][Full Text] [Related]
8. Telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation.
Rinfret S; Rodés-Cabau J; Bagur R; Déry JP; Dorais M; Larose E; Barbeau G; Gleeton O; Nguyen CM; Noël B; Proulx G; Roy L; Taillon I; De Larochellière R; Bertrand OF;
Heart; 2013 Apr; 99(8):562-9. PubMed ID: 23434769
[TBL] [Abstract][Full Text] [Related]
9. Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry).
Schoos M; Chandrasekhar J; Baber U; Bhasin A; Sartori S; Aquino M; Vogel B; Farhan S; Sorrentino S; Kini A; Kruckoff M; Moliterno D; Henry TD; Weisz G; Gibson CM; Iakovou I; Colombo A; Steg PG; Witzenbichler B; Chieffo A; Cohen D; Stuckey T; Ariti C; Dangas G; Pocock S; Mehran R
Am J Cardiol; 2017 Sep; 120(6):904-910. PubMed ID: 28778417
[TBL] [Abstract][Full Text] [Related]
10. Adherence to antiplatelet therapy after percutaneous coronary intervention: a population study in a region of Italy.
Pinnarelli L; Mayer F; Bauleo L; Agabiti N; Kirchmayer U; Belleudi V; Di Martino M; Autore C; Ricci R; Violini R; Fusco D; Davoli M; Perucci CA
J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):230-7. PubMed ID: 25325532
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet therapy for improving post-PCI outcomes: interpreting current treatment guidelines for optimal management of the post-ACS patient.
Cross J
Am J Manag Care; 2009 Mar; 15(2 Suppl):S48-53. PubMed ID: 19355809
[TBL] [Abstract][Full Text] [Related]
12. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
Larsen SB; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
[TBL] [Abstract][Full Text] [Related]
13. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2.
Tada T; Natsuaki M; Morimoto T; Furukawa Y; Nakagawa Y; Byrne RA; Kastrati A; Kadota K; Iwabuchi M; Shizuta S; Tazaki J; Shiomi H; Abe M; Ehara N; Mizoguchi T; Mitsuoka H; Inada T; Araki M; Kaburagi S; Taniguchi R; Eizawa H; Nakano A; Suwa S; Takizawa A; Nohara R; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
Circ Cardiovasc Interv; 2012 Jun; 5(3):381-91. PubMed ID: 22619260
[TBL] [Abstract][Full Text] [Related]
14. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
Valgimigli M; Campo G; de Cesare N; Meliga E; Vranckx P; Furgieri A; Angiolillo DJ; Sabatè M; Hamon M; Repetto A; Colangelo S; Brugaletta S; Parrinello G; Percoco G; Ferrari R;
Circulation; 2009 Jun; 119(25):3215-22. PubMed ID: 19528337
[TBL] [Abstract][Full Text] [Related]
15. Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia).
Campo G; Tebaldi M; Vranckx P; Biscaglia S; Tumscitz C; Ferrari R; Valgimigli M
J Am Coll Cardiol; 2014 Feb; 63(6):506-12. PubMed ID: 24161321
[TBL] [Abstract][Full Text] [Related]
16. Non-adherence to aspirin in patients undergoing coronary stenting: negative impact of comorbid conditions and implications for clinical management.
Cuisset T; Quilici J; Fugon L; Cohen W; Roux P; Gaborit B; Molines L; Fourcade L; Bonnet JL; Carrieri P
Arch Cardiovasc Dis; 2011 May; 104(5):306-12. PubMed ID: 21693367
[TBL] [Abstract][Full Text] [Related]
17. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
18. The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease.
Würtz M; Grove EL; Kristensen SD; Hvas AM
Heart; 2010 Mar; 96(5):368-71. PubMed ID: 19910291
[TBL] [Abstract][Full Text] [Related]
19. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
[TBL] [Abstract][Full Text] [Related]
20. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]